The Vox Markets Podcast / Duncan Peyton, CEO of 4D Pharma explains the reasons behind their merger and intention to seek a NASDAQ listing

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.